{SeO(OH)} Bridging Lanthanide-Containing Antimono-Seleno-Tungstates.

Inorg Chem

College of Chemistry and Chemical Engineering & Green Catalysis and Synthesis Key Laboratory of Xinyang City, Xinyang Normal University, Xinyang, Henan 464000, China.

Published: May 2024

A series of new trigonal pyramidal {SeO(OH)} bridging lanthanide-containing antimono-seleno-tungstates [HN(CH)]NaCsH[LnSeWO(OH)(HO)(SbWO)(SeWO)(SeSbWO)]·32HO [Ln = Tb (), Dy (), Ho (), Er ()] have been prepared by the synthetic strategy of simultaneously using the antimonotungstate precursor and simple material in an acidic aqueous solution and structurally characterized by single-crystal X-ray diffraction, powder X-ray diffraction, IR spectrometry, and thermogravimetric analysis. Their molecular structures contain an unprecedented hexameric polyoxoanion [LnSeWO(OH)(HO)(SbWO)(SeWO)(SeSbWO)] constituted by two equivalent trimeric subunits LnWO(HO)(SbWO)(SeWO)(SeSbWO) bridged via two μ-{SeO(OH)} linkers. Furthermore, the catalytic oxidation of various aromatic sulfides and sulfur mustard simulant 2-chloroethyl ethyl sulfide (CEES) by compound as the heterogeneous catalyst has been investigated, exhibiting high conversion and selectivity as well as good stability and recyclability.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.inorgchem.4c00767DOI Listing

Publication Analysis

Top Keywords

{seooh} bridging
8
bridging lanthanide-containing
8
lanthanide-containing antimono-seleno-tungstates
8
x-ray diffraction
8
antimono-seleno-tungstates series
4
series trigonal
4
trigonal pyramidal
4
pyramidal {seooh}
4
antimono-seleno-tungstates [hnch]nacsh[lnsewoohhosbwosewosesbwo]·32ho
4
[hnch]nacsh[lnsewoohhosbwosewosesbwo]·32ho [ln
4

Similar Publications

Diselenide-Bridged Doxorubicin Dimeric Prodrug: Synthesis and Redox-Triggered Drug Release.

Molecules

April 2024

State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.

The diselenide bond has attracted intense interest in redox-responsive drug delivery systems (DDSs) in tumor chemotherapy, due to its higher sensitivity than the most investigated bond, namely the disulfide bond. Here, a diselenide-bridged doxorubicin dimeric prodrug (D-DOX) was designed by coupling two doxorubicin molecules with a diselenodiacetic acid (DSeDAA) molecule via α-amidation, as a redox-triggered drug self-delivery system (DSDS) for tumor-specific chemotherapy. The drug release profiles indicated that the D-DOX could be cleaved to release the derivatives selenol (DOX-SeH) and seleninic acid (DOX-SeOOH) with the triggering of high GSH and HO, respectively, indicating the double-edged sword effect of the lower electronegativity of the selenide atom.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!